<DOC>
	<DOCNO>NCT02506023</DOCNO>
	<brief_summary>The purpose study determine female hemophilia A carrier respond medication call DDAVP ( Desmopressin ) .</brief_summary>
	<brief_title>Characterization Laboratory Response DDAVP Adult Hemophilia A Carriers</brief_title>
	<detailed_description>DDAVP ( Desmopressin ) commonly use treatment person bleed disorder hemophilia , von Willebrand disease , qualitative platelet disorder help clot good . The investigator want assess increase subject ' clot factor response intravenous DDAVP ( Desmopressin ) level internal clotting factor measure different time medication give . The investigator compare response DDAVP ( Desmopressin ) adult hemophilia A carrier woman diagnosis qualitative platelet dysfunction .</detailed_description>
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<mesh_term>Deamino Arginine Vasopressin</mesh_term>
	<criteria>Inclusion criterion hemophilia A carrier : Females 1860 year age time enrollment Genetically verify obligate hemophilia A carrier ( mother 2 boy hemophilia A , daughter father hemophilia A mother son another male relative hemophilia A ) To stratify patient carriage mutation type 10 hemophilia carrier mild mutation predict lead reduce FVIII secretion , protein stability thrombin cleavage site interference 10 hemophilia carrier severe mutation lead predict negative cross reactive material select . Predicted FVIII function mutation verify EAHAD ( European Association Haemophilia Allied Disorders ) Coagulant Factor Variant Database www.eahaddb.org ) Weight &gt; 40kg ensure volume blood drawn within accept safe range Inclusion criterion nonhemophilia A carrier ( Females mild qualitative platelet dysfunction ) : Females 1860 year age time enrollment Whole blood platelet rich plasma lumiaggregometry consistent reduce aggregation least 1 agonist least one occasion ( exclude evidence Glanzmanns Thrombasthenia Bernard Soulier Syndrome ) determine primary hematologist qualitative platelet disorder Agematched 10 year carrier enrol Weight &gt; 40kg ensure volume blood drawn within accept safe range Personal history concomitant bleed clot disorder Cardiac condition require daily use Aspirin Clopidogrel Inability comply fluid restriction protocol 24 hour follow Desmopressin ( DDAVP ) Personal history myocardial infarction , renal hepatic insufficiency epilepsy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Factor VIII antigen</keyword>
	<keyword>von Willebrand factor ( vWF ) antigen</keyword>
	<keyword>Mutation type</keyword>
</DOC>